Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy Academic Article Article uri icon

Overview

MeSH Major

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Immunotherapy, Adoptive
  • Ovarian Neoplasms

abstract

  • Our small retrospective series suggest that the platinum-resistant category is heterogenous and includes patients who may respond to retreatment with platinum-based agents. This group includes the patients with prior platinum responses and early progression. However, patients without an objective response to the last prior platinum therapy or more than three intervening treatments are unlikely to respond to subsequent platinum therapy.

publication date

  • October 2003

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0090-8258(03)00464-5

PubMed ID

  • 14529671

Additional Document Info

start page

  • 123

end page

  • 9

volume

  • 91

number

  • 1